AtenololAntihypertensive AgentsHypertensionBlood PressureDiureticsHydrochlorothiazideAdrenergic beta-AntagonistsMethyldopaSodium Chloride Symporter InhibitorsAmlodipineCalcium Channel BlockersAngiotensin-Converting Enzyme InhibitorsPropanolaminesHydralazineDoxazosinThiazidesChlorthalidoneHeart RateTrichlormethiazideBlood Pressure Monitoring, AmbulatoryNifedipineMyocytes, CardiacBlood Pressure DeterminationDrug Therapy, CombinationIndapamideBenzothiadiazinesRats, Inbred SHRLisinoprilAngiotensin II Type 1 Receptor BlockersEnalaprilPropranololMetoprololDihydropyridinesBendroflumethiazideDouble-Blind MethodCaptoprilCardiac OutputTetrazolesTreatment OutcomeHeartAngiotensin Receptor AntagonistsTime FactorsGuanabenzClonidineLosartanHypertrophy, Left VentricularPulseHypertension, RenalRisk FactorsAdrenergic beta-1 Receptor AntagonistsClinical Trials as TopicSystolePatient ComplianceBenzimidazolesHemodynamicsAdrenergic alpha-AntagonistsFollow-Up StudiesProspective StudiesReninPerindoprilArrhythmias, CardiacBisoprololDrug PrescriptionsMinoxidilLabetalolCardiovascular DiseasesRenin-Angiotensin SystemDihydralazineCardiac Surgical ProceduresNitrendipineDrug UtilizationNordefrinDose-Response Relationship, DrugRats, Inbred WKYPrazosinDeath, Sudden, CardiacBiphenyl CompoundsRetrospective StudiesDiastolePhysician's Practice PatternsKidney Failure, ChronicMedication AdherenceHypertension, RenovascularPindololRandom AllocationHypertension, MalignantKidneyReserpinePregnancy Complications, CardiovascularCohort StudiesEchocardiographyCeliprololRandomized Controlled Trials as TopicAcebutololMyocardiumValineDrug InteractionsPractice Guidelines as TopicCardiomegalyDrug Costs